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Summary We have proposed that diacylglycerol hydroperoxide-induced unregulated signal
transduction causes oxidative stress-related diseases. In this study, we investigated which
molecular species of diacylglycerol hydroperoxide activated human peripheral neutrophils. All
diacylglycerol hydroperoxides, diacylglycerol hydroxides, and diacyglycerols tested in the
present study induced superoxide production by neutrophils. The ability to activate neutrophils
among molecular species containing the same fatty acid composition was as follows; diacylglycerol
hydroperoxide>diacylglycerol hydroxide≥diacylglycerol. The diacylglycerol hydroperoxide
composed of linoleate was a stronger activator for neutrophils than that composed of arachidonate.
1-Palmitoyl-2-linoleoylglycerol hydroperoxide (PLG-OOH) was the strongest stimulator for
neutrophils. We reconfirmed that PLG-OOH activated protein kinase C (PKC) in neutrophils.
PLG-OOH induced the phosphorylation of p47phox, a substrate of PKC and a cytosolic component
of NADPH oxidase, in neutrophils, as did N-formyl-methionyl-leucyl-phenylalanine or 4β-
phorbol-12β-myristate-13α-acetate. Moreover, the time course of p47phox phosphorylation was
comparable to that of superoxide production. These results suggest that PLG-OOH activated
intracellular protein kinase C. PLG-OOH, produced via an uncontrolled process, can act as a
biological second messenger to cause inflammatory disease from oxidative stress.
Key Words: 1-palmitoyl-2-linoleoylglycerol hydroperoxide, neutrophil, oxidative stress, protein
kinase C, p47phox
Introduction
Lipid oxidation products are formed by free radicals in vivo
[1–4]. Recently, various lipid oxidation products (such as
phosphatidylserine hydroperoxide, cardiolipin hydroperoxide,
4-hydroxy-2-nonenal and 8-isoprostane) have attracted
much attention as signaling molecules [5–11]. For example,
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phosphatidylserine hydroperoxide [5,  11] and cardiolipin
hydroperoxide [5, 6] participate in the apoptotic process.
We have previously reported that diacylglycerol (DAG)
hydroperoxide (DAG-OOH), mainly dilinoleoylglycerol
hydroperoxide, activated rat brain protein kinase C (PKC)
[12] as strongly as 4β-phorbol-12β-myristate-13α-acetate
(PMA), a powerful PKC activator [13]. DAG-OOH would
be formed via the hydrolysis of phospholipid hydroperoxide
by the action of phospholipase C (PLC) [14]. Oxidized
phospholipids are formed by the oxidation of membrane
phospholipids, since lipids are vulnerable to free radical-
induced oxidation [15]. This process is unregulated since it
does not mediate a receptor in the biomembrane. PMA
induces various diseases, such as cancer, via PKC activation
[16, 17], but it is not a physiological molecule. Therefore,
DAG-OOH is expected to work as a physiological PKC
activator, which induces oxidative stress-related diseases
(such as cancer, inflammatory disease, autoimmune disease,
and atherosclerosis) [15].
We have also reported that 1-palmitoyl-2-linoleoylglycerol
hydroperoxide (PLG-OOH) induced superoxide (O2˙−)
production by human peripheral neutrophils [18]. Since
other molecular species of DAG-OOH can be formed in
the biological systems, it is important to confirm which
molecular species of DAG-OOH activates neutrophils. O2˙−
is produced by human neutrophils via both PKC-dependent
and -independent pathways [19, 20]. Therefore, we examined
which pathway occurred in DAG-OOH-stimulated PMNs.
PKC inhibitors, such as chelerythrine, staurosporine, and H-7,
suppressed the production of O2˙− from neutrophils activated by
DAG-OOH [18], but this is indirect evidence. Since p47phox,
a cytosolic component of NADPH oxidase, is phosphorylated
by PKC when O2˙− is generated from neutrophils, the detection
of phosphorylated p47phox is direct evidence for PKC activation
in neutrophils [21]. If phosphorylation of p47phox is observed in
DAG-OOH-stimulated neutrophils, it indicates the activation
of PKC in neutrophils by DAG-OOH.
In the present study, we investigated which molecular
species of DAG-OOH activate human peripheral neutrophils







choline, 1,2-dioleoylglycerol (OOG), and 1-oleoyl-2-acetyl-
glycerol (OAG) were purchased from Funakoshi Co. Ltd.
(Tokyo, Japan). PMA, N-formyl-methionyl-leucyl-phenyl-
alanine (fMLP), bacillus cereus PLC (type IX), and soybean
lipoxygenase (type 1B) were obtained from Sigma Chemical
Co. (St. Louis, MO). 2-Methyl-6-(p-methoxyphenyl)-3,7-
dihydroimidazo [1,2-a] pyrazin-3-one (MCLA) was obtained
from Tokyo Chemical Industry Co. Ltd. (Tokyo, Japan).
Chelex®100 was purchased from Bio-Rad Laboratories, Inc.
(Hercules, CA). [32P]-Orthophosphoric acid was purchased
from NEN™ Life Science Products, Inc. (Boston, MA).
Solvents and other reagents were of the highest grade
available. Rabbit polyclonal anti-p47phox antibody was
from Dr. Naoki Okamura (Hiroshima University School of
Medicine) [22].
Preparation of various molecular species of diacylglycerol,
their hydroperoxides and their hydroxides
Various molecular species of DAG, DAG-OOH and DAG
hydroxide (DAG-OH) were prepared as previously reported
[18] with some modifications. Phosphatidylcholine (PC)
was purified using reversed-phase HPLC prior to use. PC
(6 µg) was oxidized with lipoxygenase (2.6 mg) in 0.2 M
borate buffer treated with Chelex 100 (pH 9, 20 ml)
containing 3 mM sodium deoxycholate for 20 min by mixing
vigorously at room temperature under air. If necessary,
sodium borohydride was added to the reaction mixture to
reduce the phosphatidylcholine hydroperoxide (PC-OOH)
after the reaction was over. Solid phase extraction was
performed with a Sep-Pak C18 cartridge (10 g, Waters Co.,
Milford, MA), which was pretreated with 100 ml of 100 µM
EDTA aqueous solution. The reaction mixture containing
PC-OOH or PC hydroxide (PC-OH) was applied to the
cartridge after it was equilibrated with 100 ml of water. PC-
OOH or PC-OH was eluted with 100 ml of methanol after
washing with 200 ml of water. PC-OOH or PC-OH was
purified with reversed-phase HPLC after the eluate was
concentrated with a rotary evaporator, and it was filtered
with a 0.22 µm filter (MILLEX®-GP; Millipore Co., Bedford,
MA). The PC, PC-OOH, or PC-OH was hydrolyzed by
PLC in 50 mM Tris-HCl (pH 7.4) containing 40% methanol
at 37°C. The reaction was monitored with HPLC. The
DAG, DAG-OOH or DAG-OH formed was extracted with
chloroform/methanol (2/1, by volume) three times. After the
concentration of the collected lower layer using a rotary
evaporator, DAG, DAG-OOH or DAG-OH was purified by
HPLC with a CAPCELPAK C18 column (type: UG120,
20 × 250 mm, 5 µm, Shiseido Co. Ltd., Tokyo, Japan) and
methanol/2-propanol (=17/3, by volume) as the mobile phase
at a flow rate of 10 ml/min. Their elution times were as follows;
15.8 min (PLG), 20.5 min (1-stearoyl-2-linoleoylglycerol;
SLG), 15.5 min (1-palmytoyl-2-arachidonoylglycerol; PAG),
19.0 min (1-stearoyl-2-arachidonoylglycerol; SAG), 14.5 min
(1,3-dilinoleoylglycerol; 1,3-LLG), 9.3 min (PLG-OOH),
10.5 min (SLG-OOH), 9.3 min (PAG-OOH), 10.5 min (SAG-
OOH), 8.5 min (1,3-LLG-OOH), 9.3 min (PLG hydroxide;
PLG-OH), 10.3 min (SLG-OH), 9.3 min (PAG-OH) and
10.8 min (SAG-OH). DAG was monitored at 215 nm. DAG-Y. Kambayashi et al.
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OH or DAG-OOH was monitored at 234 nm. The concentration
of DAG-OOH was determined using a hydroperoxide-
specific, isoluminol chemiluminescence assay [23]. The
absence of hydroperoxide in DAG-OH and DAG was also
confirmed using this assay. The concentration of DAG-OH
was estimated from its absorbance at 234 nm using an
assumed molar extinction coefficient, 28,000 M−1cm−1 [24].
The concentration of DAG was calculated from their
weights.
Measurement of MCLA-dependent chemiluminescence
Blood was drawn from healthy volunteers. Neutrophils
were prepared as described previously [18]. A glass cuvette
containing neutrophils (5.0 × 104 cells) and 2 µmol of MCLA
in 1,990 µl of Hanks’ balanced salt solution containing 1.3 mM
calcium ion and 0.9 mM magnesium ion was incubated at
37°C for 3 min under air. Thereafter, 10 µl of a stimulator,
such as 800 µM or 1.6 mM DAG, DAG-OOH, or DAG-OH,
or 200 µM fMLP dissolved in methanol, was added to the
reaction mixture using a microsyringe. MCLA-dependent
luminescence (O2˙− production [25]) was recorded using a
luminescence reader (type: BLR-301, Aloka Co. Ltd.,
Tokyo, Japan).
Detection of phosphorylated p47phox
Neutrophils were suspended in calcium ion, phosphate-
free buffer (10 mM HEPES, 137 mM sodium chloride,
5.4 mM potassium chloride, 5.6 mM D-glucose, 0.8 mM
magnesium chloride, and 0.025% BSA, pH 7.4) at 1.0 × 107
cells/ml [26]. [32P]-Orthophosphate was added to the
neutrophil suspension at 100 µCi/107 cells and the cells were
incubated at 37°C for 60 min with gentle mixing every
10 min. After 3 washes, calcium ion, phosphate-free buffer
was added to the pellet (1.0 × 107 cells/ml).
Neutrophils (1.0 × 107 cells/ml × 300 µl) were suspended
in phosphate-free buffer (695 µl; 10 mM HEPES, 137 mM
sodium chloride, 5.4 mM potassium chloride, 1.26 mM
calcium chloride, 5.6 mM D-glucose, 0.8 mM magnesium
chloride, and 0.025% BSA, pH 7.4) [26]. After preincubation
for 1 min at 37°C, the reaction was started by adding
5 µl of stimulator dissolved in methanol (1.6 mM PLG-
OOH, 200 µM fMLP or 640 nM PMA). The reaction was
stopped by centrifugation (12,000 rpm × 10 s) at the times
described in the figure legends, and the supernatant was
removed. Two hundred microliters of lysis buffer (200 µM
phenylmethylsulfonyl fluoride, 3 µM leupepsin, 2 µM pep-
statin, 1 µM staurosporine, 100 nM calysurin A, 100 µM o-
vanadate, 150 mM NaCl, and 1% NP-40 in 50 mM Tris-HCl
(pH 8); protease inhibitor cocktail (Boehringer Mannheim,
Mannheim, Germany) plus staurosporine) was added to the
pellet and mixed vigorously for 1 min. After centrifugation,
5 µl of rabbit polyclonal anti-p47phox antibody was added to
the supernatant and the solution was rotated at 4°C for 1.5 h.
Eighty microliters of 10% protein A sepharose CL-4B in
NET gel buffer (Tris buffer containing NP-40, EDTA, and
gelatin) was added and the solution was rotated at 4°C for
1 h. After 3 washes of the precipitate with lysis buffer, 40 µl
of SDS-PAGE sample buffer was added and the samples
were boiled at 100°C for 5 min. Electrophoresis was
performed with a 10% polyacrylamide gel. A low molecular
weight marker (Bio-Rad Laboratories, Inc., Herculus, CA)
was used. Phosphorylated protein was detected using auto-
radiography.
Results
Synthesis of various molecular species of DAG, DAG-OOH,
and DAG-OH
We first synthesized various molecular species of DAG-
OOH to investigate which molecular species of DAG-OOH
activate neutrophils. PC-OOH was formed by the oxidation
of PC with lipoxygenase and it was hydrolyzed with PLC to
form DAG-OOH, as described in the “Materials and
Methods” section (Fig. 1). 1,3-LLG-OOH was synthesized by
autoxidation of 1,3-LLG with α-tocopherol. The structures
of various molecular species of DAG-OOH used in the
present study are shown in Fig. 2. Various molecular species
of DAG-OH were synthesized via the hydrolysis of PC-OH,
which was formed by the reduction of PC-OOH with sodium
borohydride, with PLC (Fig. 1). Various molecular species
of DAG were synthesized by the hydrolysis of PC with PLC
(Fig. 1).
Activation of neutrophils by various molecular species of
DAG, DAG-OOH, or DAG-OH
The activation of neutrophils by various molecular
species of DAG, DAG-OOH, or DAG-OH (4 µM each) was
investigated (Fig. 3). Activation of neutrophils was evaluated
using maximum MCLA-dependent luminescence intensity,
which represents the maximum rate of O2˙− formation. No
light emission was observed when only methanol was added
to the neutrophil suspension (data not shown). The DAG-
Fig. 1.  Procedures for the synthesis of diacyglycerol, diacyl-
glycerol hydroperoxide, and diacylglycerol hydroxide.Diacylglycerol Hydroperoxides Activate Neutrophils
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OOH or DAG-OH composed of linoleate hydroperoxide
(hydroxide) was a more powerful activator of neutrophils than
that composed of arachidonate hydroperoxide (hydroxide)
(Fig. 3A, B). The activation of neutrophils by 1,3-LLG-
OOH was weaker than that by any 1,2-DAG-OOH, as
reported previously [18]. The difference in the fatty acid
composition of DAG species, including 1,2-dioleoylglycerol
(OOG), which is widely used as a PKC activator, did not
affect the maximum luminescence intensity (Fig. 3C). PLG-
OOH was the strongest activator of neutrophils among the
various DAG, DAG-OOH, and DAG-OH species tested in
the present study. Moreover, the activation of neutrophils by
PLG-OOH was significantly stronger than that by 1-oleoyl-2-
acetylglycerol (OAG), which is generally used as a stimulator
of cells (Fig. 3A). Based on these findings, PLG-OOH was
used in the subsequent experiments. The ability to activate
neutrophils among molecular species containing the same
fatty acid composition was as follows; DAG-OOH>DAG-
OH≥DAG. This order did not change when 8 µM of
stimulator was used (data not shown). No significant
Fig. 2. Structures of various molecular species of diacylglycerol hydroperoxide used in the present study.
Fig. 3.  Activation of neutrophils by diaclyglycerol hydroperoxides (A), diacylglycerol hydoxides (B), or diaclyglycerols (C). The
maximum MCLA-dependent luminescence intensity was measured as the rate of superoxide anion formation from neutrophils
(2.5 × 104 cells/ml). The concentration of each stimulator used here was 4 µM. One micromolar MCLA was used in this
experiment. Results are expressed as means ± standard deviations (n = 5). Abbreviations used in the figures are as follows;
PAG, 1-palmitoyl-2-arachidonoylglycerol; PLG, 1-palmitoyl-2-linoleoylglycerol; SAG, 1-stearoyl-2-arachidonoylglycerol; SLG,
1-stearoyl-2-linoleoylglycerol; 1,3-LLG, 1,3-dilinoleoylglycerol; OAG, 1-oleoyl-2-acetylglycerol; OOG, 1,2-dioleoylglycerol; -OOH,
hydroperoxide; -OH, hydroxide.Y. Kambayashi et al.
J. Clin. Biochem. Nutr.
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difference between the activation of PKC by DAG-OOH
and that by DAG-OH in vitro has been reported [12]. Further
studies are needed to elucidate why different results were
obtained in vitro versus ex vivo.
Phosphorylation of p47phox in neutrophils by the stimulation
of DAG-OOH
The activation of PKC in neutrophils by DAG-OOH was
reconfirmed. p47phox is a cytosolic factor of NADPH oxidase,
and known as a substrate of PKC [21]. When only methanol
(0.5% to solution) was added to the neutrophil suspension,
p47phox was not phosphorylated after 2 min at 37°C (Fig. 4).
p47phox was phosphorylated in 8 µM PLG-OOH-stimulated
neutrophils, as in PMA (3 nM)-stimulated or fMLP (1 µM)-
stimulated neutrophils (Fig. 4).
The phosphorylated p47phox at 1 min after stimulation
decreased at 2 min in both fMLP (1 µM)-stimulated and PLG-
OOH (8 µM)-stimulated neutrophils (Fig. 5A). This change
was comparable to that in MCLA-dependent luminescence
intensity (1 µM fMLP; Fig. 5B, 8 µM PLG-OOH; Fig. 5C).
These results suggest that p47phox was phosphorylated by
PKC in PLG-OOH-stimulated neutrophils. In fact, the
production of O2˙− was inhibited by serine/threonine kinase
inhibitors and PKC inhibitors, such as staurosporine, H-7,
and chelerythrine [18].
Discussion
The activation of human neutrophils by various molecular
species of DAG, DAG-OOH, and DAG-OH was investigated
in the present study. In order of the amount of PC in rat liver,
the species ranked as follows; SAPC (16.1%)>SLPC
(14.8%)>PLPC (14.1%)>PAPC (9.7%) [27]. In terms of the
amount of fatty acid in the phospholipids of mammalian cells,
fatty acid ranked as follows; palmitate (33%)>oleate (25%)>
stearate (12%)>linoleate (10%)>arachidonate (8%) (human
neutrophil phospholipids) [28], palmitate (33%)>arachidonate
(19%)>stearate (16%)>oleate (13%)>linoleate (7%) (human
coronary artery phospholipids) [29], and linoleate (25%)>
stearate (24%)>palmitate (17%)>arachidonate (16%) (rat
heart phosphatidylcholine at 100 days old) [30]. Almost all
phospholipids in mammalian cells have a saturated fatty acid
at the sn-1 position and an unsaturated fatty acid at the sn-2
position. Oleate is not easily oxidized by free radicals.
Fig. 4. Phosphorylation  of  p47phox in neutrophils (3 × 106 cells/
ml) activated by various stimulators. Lane 1; Methanol
(0.5% of solution) was used in the control experiment
(2 min). Lane 2; Three nanomolar 4β-phorbol-12β-
myristate-13α-acetate (PMA) was used, and stimulation
was stopped at 5 min. Lane 3; One micromolar N-formyl-
methionyl-1-leucyl-phenylalnine (fMLP) was used, and
stimulation was stopped at 2 min. Lane 4; Eight
micromolar 1-palmitoyl-2-linoleoylglycerol hydroperoxide
(PLG-OOH) was used, and stimulation was stopped at
2m i n .
Fig. 5.  Time course of p47phox phosphorylation in neutrophils (3 × 106 cells/ml) stimulated by 1 µM N-formyl-methionyl-1-leucyl-
phenylalnine (fMLP) or 8 µM 1-palmitoyl-2-linoleoylglycerol hydroperoxide (PLG-OOH) (A). Time-dependent change in
MCLA-dependent luminescence from 1 µM fMLP-stimulated neutrophils (2.5 × 104 cells/ml) (B) and 8 µM PLG-OOH-
stimulated neutrophils (2.5 × 104 cells/ml) (C).Diacylglycerol Hydroperoxides Activate Neutrophils
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Therefore, diacylglycerols with palmitate or stearate at the sn-
1 position and linoleate or arachidonate at the sn-2 position
were used in the present study. Although all molecular
species of DAG, DAG-OOH, and DAG-OH containing these
fatty acids activated human neutrophils, PLG-OOH was the
most potent activator.
Human neutrophils have PKCα and PKCδ [31]. We also
detected these PKC isoforms in neutrophils in the Western
blot analysis (data not shown). Recently, it was found that
DAG-OOH activated various PKC isoforms in vitro, but
only PKCα and PKCδ were activated by DAG-OOH more
strongly than by DAG (our unpublished data). These PKC
isoforms may be involved in the activation of neutrophils by
PLG-OOH.
Calcium, phospholipid-independent activity of bovine
brain PKC is increased by oxidation of the regulatory
domain of PKC by hydrogen peroxide or periodate [32, 33].
Even PKC in cells (PKCγ in N/N1003A cells [34] and PKCδ
in COS-7 cells [35]) was oxidized by hydrogen peroxide and
was activated. Oxidation of PKC by PLG-OOH might
cause neutrophil activation in the present study. However,
8 µM PC-OOH, linoleate hydroperoxide, and hydrogen
peroxide did not induce production of O2˙− by human neutro-
phils in our previous study [18]. Moreover, we reconfirmed
the activation of PKC in neutrophils by PLG-OOH using
p47phox phosphorylation in the present study. Therefore,
PLG-OOH might activate PKC in neutrophils directly.
PKCδ is activated via tyrosine phosphorylation by high
concentrations (mM) of hydrogen peroxide [36, 37]. Further
study is needed to clarify whether tyrosine residues of PKCδ
in neutrophils are phosphorylated by PLG-OOH stimulation.
It has been suggested that oxidative stress causes disease,
cancer, and aging through the accumulation of oxidative
damage, including the oxidation of DNA, lipids, and proteins
[15]. However, there is little direct evidence that oxidative
damage is the cause of various diseases, although much
indirect evidence has been reported. We previously proposed
that DAG-OOH, formed by the actions of PLC after the
oxidation of biomembrane phospholipids by free radicals
[14], activates PKC, and causes diseases such as cancer,
since this signal is not regulated by receptors (Fig. 6) [12,
16]. In the present study, we confirmed that PLG-OOH
activates intracellular PKC. This result suggests that our
proposal occurs in biological systems.
The activation of neutrophils is involved in inflammatory
diseases (for example; acute inflammatory liver injury [38]
and chronic inflammatory airway disease [39]). PKC is
activated under oxidative stress [40] (for example; cardiac
reperfusion [41], diabetic nephropathy [42] and ischemia
reperfusion of skeletal muscle [43]). In some cases, PLG-
OOH may activate PKC.
In summary, various molecular species of DAG, DAG-
OOH and DAG-OH were synthesized. All the DAG-OOHs
tested in the present study activated neutrophils, but PLG-OOH
was the most potent activator. When PLG-OOH stimulated
neutrophils, O2˙− was produced via the phosphorylation of
p47phox by PKC. These results suggest that PLG-OOH
activates PKC in cells. Therefore, PLG-OOH, produced via
an uncontrolled process, can act as a second messenger in
the progression from oxidative stress-induced damage to
inflammatory disease (Fig. 6).
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